Literature DB >> 33371336

Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.

Qing-Rong Liu1, Ana Canseco-Alba2, Ying Liang3, Hiroki Ishiguro4, Emmanuel S Onaivi2.   

Abstract

There are two well-characterized cannabinoid receptors (CB1R and CB2R and other candidates): the central nervous system (CNS) enriched CB1R and peripheral tissue enriched CB2R with a wide dynamic range of expression levels in different cell types of human tissues. Hepatocytes and neurons express low baseline CB1R and CB2R, respectively, and their cell-type-specific functions are not well defined. Here we report inducible expression of CB1R in the liver by high-fat and high sugar diet and CB2R in cortical neurons by methamphetamine. While there is less controversy about hepatocyte CB1R, the presence of functional neuronal CB2R is still debated to date. We found that neuron CB2R basal expression was higher than that of hepatocyte CB1R by measuring mRNA levels of specific isoform CB2A in neurons isolated by fluorescence-activated cell sorting (FACS) and CB1A in hepatocytes isolated by collagenase perfusion of liver. For in vivo studies, we generated hepatocyte, dopaminergic neuron, and microglia-specific conditional knockout mice (Abl-Cnr1Δ, Dat-Cnr2Δ, and Cx3cr1-Cnr2Δ) of CB1R and CB2R by crossing Cnr1f/f and Cnr2f/f strains to Abl-Cre, Dat-Cre, and Cx3cr1-Cre deleter mouse strains, respectively. Our data reveals that neuron and microglia CB2Rs are involved in the "tetrad" effects of the mixed agonist WIN 55212-2, CB1R selective agonist arachidonyl-2'-chloroethylamide (ACEA), and CB2R selective agonist JWH133. Dat-Cnr2Δ and Cx3cr1-Cnr2Δ mice showed genotypic differences in hypomobility, hypothermia, analgesia, and catalepsy induced by the synthetic cannabinoids. Alcohol conditioned place preference was abolished in DAT-Cnr2Δ mice and remained intact in Cx3cr1-Cnr2Δ mice in comparison to WT mice. These Cre-loxP recombinant mouse lines provide unique approaches in cannabinoid research for dissecting the complex endocannabinoid system that is implicated in many chronic disorders.

Entities:  

Keywords:  CB1 receptor; CB2 receptor; Cre-loxP system; cannabinoids; hepatocytes; in situ hybridization; microglia; neurons; tetrad effects

Mesh:

Substances:

Year:  2020        PMID: 33371336      PMCID: PMC7767340          DOI: 10.3390/ijms21249763

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  96 in total

1.  Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice.

Authors:  Jie Liu; Liang Zhou; Keming Xiong; Grzegorz Godlewski; Bani Mukhopadhyay; Joseph Tam; Shi Yin; Peter Gao; Xin Shan; James Pickel; Ramon Bataller; James O'Hare; Thomas Scherer; Christoph Buettner; George Kunos
Journal:  Gastroenterology       Date:  2012-01-31       Impact factor: 22.682

2.  Genome-wide atlas of gene expression in the adult mouse brain.

Authors:  Ed S Lein; Michael J Hawrylycz; Nancy Ao; Mikael Ayres; Amy Bensinger; Amy Bernard; Andrew F Boe; Mark S Boguski; Kevin S Brockway; Emi J Byrnes; Lin Chen; Li Chen; Tsuey-Ming Chen; Mei Chi Chin; Jimmy Chong; Brian E Crook; Aneta Czaplinska; Chinh N Dang; Suvro Datta; Nick R Dee; Aimee L Desaki; Tsega Desta; Ellen Diep; Tim A Dolbeare; Matthew J Donelan; Hong-Wei Dong; Jennifer G Dougherty; Ben J Duncan; Amanda J Ebbert; Gregor Eichele; Lili K Estin; Casey Faber; Benjamin A Facer; Rick Fields; Shanna R Fischer; Tim P Fliss; Cliff Frensley; Sabrina N Gates; Katie J Glattfelder; Kevin R Halverson; Matthew R Hart; John G Hohmann; Maureen P Howell; Darren P Jeung; Rebecca A Johnson; Patrick T Karr; Reena Kawal; Jolene M Kidney; Rachel H Knapik; Chihchau L Kuan; James H Lake; Annabel R Laramee; Kirk D Larsen; Christopher Lau; Tracy A Lemon; Agnes J Liang; Ying Liu; Lon T Luong; Jesse Michaels; Judith J Morgan; Rebecca J Morgan; Marty T Mortrud; Nerick F Mosqueda; Lydia L Ng; Randy Ng; Geralyn J Orta; Caroline C Overly; Tu H Pak; Sheana E Parry; Sayan D Pathak; Owen C Pearson; Ralph B Puchalski; Zackery L Riley; Hannah R Rockett; Stephen A Rowland; Joshua J Royall; Marcos J Ruiz; Nadia R Sarno; Katherine Schaffnit; Nadiya V Shapovalova; Taz Sivisay; Clifford R Slaughterbeck; Simon C Smith; Kimberly A Smith; Bryan I Smith; Andy J Sodt; Nick N Stewart; Kenda-Ruth Stumpf; Susan M Sunkin; Madhavi Sutram; Angelene Tam; Carey D Teemer; Christina Thaller; Carol L Thompson; Lee R Varnam; Axel Visel; Ray M Whitlock; Paul E Wohnoutka; Crissa K Wolkey; Victoria Y Wong; Matthew Wood; Murat B Yaylaoglu; Rob C Young; Brian L Youngstrom; Xu Feng Yuan; Bin Zhang; Theresa A Zwingman; Allan R Jones
Journal:  Nature       Date:  2006-12-06       Impact factor: 49.962

3.  Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD.

Authors:  Jing Han; Philip Kesner; Mathilde Metna-Laurent; Tingting Duan; Lin Xu; Francois Georges; Muriel Koehl; Djoher Nora Abrous; Juan Mendizabal-Zubiaga; Pedro Grandes; Qingsong Liu; Guang Bai; Wei Wang; Lize Xiong; Wei Ren; Giovanni Marsicano; Xia Zhang
Journal:  Cell       Date:  2012-03-02       Impact factor: 41.582

4.  Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method.

Authors:  Esam S B Salem; Kazutoshi Murakami; Toshimasa Takahashi; Elise Bernhard; Vishnupriya Borra; Mridula Bethi; Takahisa Nakamura
Journal:  J Vis Exp       Date:  2018-10-23       Impact factor: 1.355

5.  Revisiting cannabinoid receptor 2 expression and function in murine retina.

Authors:  Joanna Borowska-Fielding; Natalia Murataeva; Ben Smith; Anna-Maria Szczesniak; Emma Leishman; Laura Daily; J Thomas Toguri; Cecelia J Hillard; Julian Romero; Heather Bradshaw; Melanie E M Kelly; Alex Straiker
Journal:  Neuropharmacology       Date:  2018-08-16       Impact factor: 5.250

6.  Cloning of the human sodium lodide symporter.

Authors:  P A Smanik; Q Liu; T L Furminger; K Ryu; S Xing; E L Mazzaferri; S M Jhiang
Journal:  Biochem Biophys Res Commun       Date:  1996-09-13       Impact factor: 3.575

7.  Critique of the use of fluorescence-based reporters in Escherichia coli as a screening tool for the identification of peptide inhibitors of Aβ42 aggregation.

Authors:  Oliver Wright; Liao Zhang; Yun Liu; Tatsuya Yoshimi; Yizhi Zheng; Alan Tunnacliffe
Journal:  J Pept Sci       Date:  2012-12-16       Impact factor: 1.905

8.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

Authors:  A Zimmer; A M Zimmer; A G Hohmann; M Herkenham; T I Bonner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

9.  The endocannabinoid system controls key epileptogenic circuits in the hippocampus.

Authors:  Krisztina Monory; Federico Massa; Michaela Egertová; Matthias Eder; Heike Blaudzun; Ruth Westenbroek; Wolfgang Kelsch; Wolfgang Jacob; Rudolf Marsch; Marc Ekker; Jason Long; John L Rubenstein; Sandra Goebbels; Klaus-Armin Nave; Matthew During; Matthias Klugmann; Barbara Wölfel; Hans-Ulrich Dodt; Walter Zieglgänsberger; Carsten T Wotjak; Ken Mackie; Maurice R Elphick; Giovanni Marsicano; Beat Lutz
Journal:  Neuron       Date:  2006-08-17       Impact factor: 17.173

Review 10.  LARP6 Meets Collagen mRNA: Specific Regulation of Type I Collagen Expression.

Authors:  Yujie Zhang; Branko Stefanovic
Journal:  Int J Mol Sci       Date:  2016-03-22       Impact factor: 5.923

View more
  2 in total

1.  Chronic unpredictable stress during adolescence protects against adult traumatic brain injury-induced affective and cognitive deficits.

Authors:  Patricia B de la Tremblaye; JoDy L Wellcome; Kaitlyn Wiley; Carolyn A Lomahan; Eleni H Moschonas; Jeffrey P Cheng; Corina O Bondi; Anthony E Kline
Journal:  Brain Res       Date:  2021-06-04       Impact factor: 3.610

Review 2.  Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes.

Authors:  Qing-Rong Liu; Kanikkai Raja Aseer; Qin Yao; Xiaoming Zhong; Paritosh Ghosh; Jennifer F O'Connell; Josephine M Egan
Journal:  Front Pharmacol       Date:  2022-01-18       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.